All In Biotech

Drug Trial Radar · NCT06129864

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)

Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,145 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,145

Planned (sponsor's estimate)

Start

Dec 14, 2023

Primary completion

Apr 17, 2030

Study completion Feb 28, 2031

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 130 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who have not progressed after receiving definitive concurrent chemoradiotherapy (cCRT).

Conditions

  • Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

  • volrustomigDrug

    volrustomig

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) in participants with unresected LA-HNSCC with PD-L1 expressing tumorsTime frame: Up to approximately 8 years

Locations

306 sites in 23 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama · Recruiting

  • Research Site

    Phoenix, Arizona · Recruiting

  • Research Site

    Prescott Valley, Arizona · Active not recruiting

  • Research Site

    Springdale, Arkansas · Withdrawn

  • Research Site

    Fountain Valley, California · Recruiting

  • Research Site

    Fullerton, California · Not yet recruiting

  • Research Site

    Los Angeles, California · Recruiting

  • Research Site

    Orange, California · Withdrawn

  • Research Site

    Santa Rosa, California · Recruiting

  • Research Site

    Whittier, California · Recruiting

  • Research Site

    Aurora, Colorado · Recruiting

  • Research Site

    Colorado Springs, Colorado · Recruiting

  • Research Site

    Lone Tree, Colorado · Recruiting

  • Research Site

    Washington D.C., District of Columbia · Recruiting

  • Research Site

    Fort Myers, Florida · Recruiting

  • Research Site

    Gainesville, Florida · Withdrawn

  • Research Site

    Miami, Florida · Withdrawn

  • Research Site

    Palm Bay, Florida · Recruiting

  • Research Site

    West Palm Beach, Florida · Recruiting

  • Research Site

    Niles, Illinois · Recruiting

  • Research Site

    Des Moines, Iowa · Recruiting

  • Research Site

    Kansas City, Kansas · Completed

  • Research Site

    Louisville, Kentucky · Recruiting

  • Research Site

    Baton Rouge, Louisiana · Recruiting

  • Research Site

    Shreveport, Louisiana · Withdrawn

  • Research Site

    Baltimore, Maryland · Recruiting

  • Research Site

    Bethesda, Maryland · Recruiting

  • Research Site

    Hyattsville, Maryland · Recruiting

  • Research Site

    Towson, Maryland · Recruiting

  • Research Site

    Upper Marlboro, Maryland · Recruiting

  • Research Site

    Boston, Massachusetts · Recruiting

  • Research Site

    Fairhaven, Massachusetts · Recruiting

  • Research Site

    Ann Arbor, Michigan · Recruiting

  • Research Site

    Ann Arbor, Michigan · Withdrawn

  • Research Site

    Minneapolis, Minnesota · Recruiting

  • Research Site

    Columbia, Missouri · Withdrawn

  • Research Site

    St Louis, Missouri · Recruiting

  • Research Site

    St Louis, Missouri · Withdrawn

  • Research Site

    East Brunswick, New Jersey · Withdrawn

  • Research Site

    Hackensack, New Jersey · Recruiting

Showing 40 of 306 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.